Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Sorrento reports preliminary phase Ib results on COVI-MSC for COVID-19

Jan. 27, 2021

Microbial tyrosine metabolism protects against asthma

Jan. 27, 2021

First patient dosed in second phase II study of AD-109 in obstructive sleep apnea

Jan. 20, 2021

DMC recommends start of part 2 of COVA study of Sarconeos in COVID-19

Jan. 19, 2021

Phase II trial of dexpramipexole in moderate to severe eosinophilic asthma meets primary endpoint

Jan. 14, 2021

New trial investigates use of NAC for IPF

Jan. 12, 2021

FDA clears IND for phase I trial of PRGN-2012 for recurrent respiratory papillomatosis

Jan. 8, 2021

Cerecor reports phase II proof-of-concept data for CERC-002 in COVID-19 ARDS

Jan. 7, 2021

Windtree initiates phase II trial of lucinactant for COVID-19-associated acute lung injury

Jan. 7, 2021

Enterprise Therapeutics divulges ANO1 activators

Jan. 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...